» Articles » PMID: 27045293

The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium Ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon

Abstract

Background: Access to laboratory diagnosis can be a challenge for individuals suspected of Buruli Ulcer (BU). Our objective was to develop a clinical score to assist clinicians working in resource-limited settings for BU diagnosis.

Methododology/principal Findings: Between 2011 and 2013, individuals presenting at Akonolinga District Hospital, Cameroon, were enrolled consecutively. Clinical data were collected prospectively. Based on a latent class model using laboratory test results (ZN, PCR, culture), patients were categorized into high, or low BU likelihood. Variables associated with a high BU likelihood in a multivariate logistic model were included in the Buruli score. Score cut-offs were chosen based on calculated predictive values. Of 325 patients with an ulcerative lesion, 51 (15.7%) had a high BU likelihood. The variables identified for the Buruli score were: characteristic smell (+3 points), yellow color (+2), female gender (+2), undermining (+1), green color (+1), lesion hyposensitivity (+1), pain at rest (-1), size >5cm (-1), locoregional adenopathy (-2), age above 20 up to 40 years (-3), or above 40 (-5). This score had AUC of 0.86 (95%CI 0.82-0.89), indicating good discrimination between infected and non-infected individuals. The cut-off to reasonably exclude BU was set at scores <0 (NPV 96.5%; 95%CI 93.0-98.6). The treatment threshold was set at a cut-off ≥4 (PPV 69.0%; 95%CI 49.2-84.7). Patients with intermediate BU probability needed to be tested by PCR.

Conclusions/significance: We developed a decisional algorithm based on a clinical score assessing BU probability. The Buruli score still requires further validation before it can be recommended for wide use.

Citing Articles

Volatile organic compound detection of Buruli ulcer disease: Headspace analysis of Mycobacterium ulcerans and used gauzes of Buruli-compatible ulcers.

Chudy S, Phanzu D, Kolk A, Sopoh G, Barogui Y, Tzfadia O PLoS Negl Trop Dis. 2024; 18(9):e0012514.

PMID: 39312571 PMC: 11449299. DOI: 10.1371/journal.pntd.0012514.


Evaluation of an electricity-independent method for IS2404 Loop-mediated isothermal amplification (LAMP) diagnosis of Buruli ulcer in resource-limited settings.

Ahortor E, Gwira T, Mahazu S, Erber A, Ablordey A PLoS Negl Trop Dis. 2024; 18(8):e0012338.

PMID: 39141676 PMC: 11346967. DOI: 10.1371/journal.pntd.0012338.


Stigma, psychosocial and economic effects of yaws in the Philippines: an exploratory, qualitative study.

Dofitas B, Kalim S, Toledo C, Richardus J Trop Med Health. 2022; 50(1):43.

PMID: 35794656 PMC: 9258159. DOI: 10.1186/s41182-022-00433-4.


Impact of common skin diseases on children in rural Côte d'Ivoire with leprosy and Buruli ulcer co-endemicity: A mixed methods study.

Yotsu R, Comoe C, Ainyakou G, Konan N, Akpa A, Yao A PLoS Negl Trop Dis. 2020; 14(5):e0008291.

PMID: 32421709 PMC: 7274456. DOI: 10.1371/journal.pntd.0008291.


Diagnostic Value of Histological Analysis of Punch Biopsies in Suspected Cutaneous Buruli Ulcer: A Study on 32 Cases of Confirmed Buruli Ulcer in Cameroon.

Ibrahim Y, Masouye I, Tschanz E, Atangana P, Etard J, Serafini M Dermatopathology (Basel). 2019; 6(2):28-36.

PMID: 31192197 PMC: 6547264. DOI: 10.1159/000498969.


References
1.
Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K . Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis. 2002; 8(2):167-70. PMC: 2732443. DOI: 10.3201/eid0802.010119. View

2.
Rondini S, Mensah-Quainoo E, Troll H, Bodmer T, Pluschke G . Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol. 2003; 41(9):4231-7. PMC: 193839. DOI: 10.1128/JCM.41.9.4231-4237.2003. View

3.
Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, Junghanss T . Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health. 2008; 13(2):191-8. DOI: 10.1111/j.1365-3156.2007.01990.x. View

4.
En J, Goto M, Nakanaga K, Higashi M, Ishii N, Saito H . Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study. Infect Immun. 2008; 76(5):2002-7. PMC: 2346717. DOI: 10.1128/IAI.01588-07. View

5.
Herbinger K, Adjei O, Awua-Boateng N, Nienhuis W, Kunaa L, Siegmund V . Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis. 2009; 48(8):1055-64. DOI: 10.1086/597398. View